NAD reviews Nutrex claim
This article was originally published in The Tan Sheet
The claim that Vitrix Maximum Impact dietary supplement enables users to "have the best sex" of their lives is not mere puffery in the context it is used by Nutrex, but qualifies as an unsupported claim, says the National Advertising Division. While the phrase on its own could be puffery, the Council of Better Business Bureaus unit decides Feb. 2 that additional claims of testosterone boosting and sexual performance improvement render the claim unsupported by science. The Council for Responsible Nutrition challenged Oviedo, Fla.-based Nutrex's claim, arguing that scientific literature on the testosterone-stimulating qualities of the herb Tribulus terristris and other ingredients in Vitrix should not apply to the product. Nutrex says it has discontinued or modified several product claims as a result of the NAD decision, despite disagreeing with aspects of it
You may also be interested in...
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.
Execs On The Move: Medical Microinstruments Gets New CEO; Changes At iRhythm; Aethlon Makes A Promotion
Corindus Vascular Robotics CEO made a lateral move to Medical Microinstruments; iRhythm hires a new CEO, while the former CEO stays on as a director; Aethlon promotes a director to chief business officer; and more.